BioSpace News Archive

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications (sNDAs) for PIFELTRO™

Murdoch University and Bruker (Nasdaq: BRKR) today announced a strategic collaboration that will help transform the prevention and diagnosis of disease and personalised health around the world

3,000 Blue Cross Blue Shield of Massachusetts associates are volunteering at service projects across the Commonwealth focused on improving the health of children and families as part of the company’s annual Service Day.

Eclipse, a leading manufacturer of regenerative medicine devices, has upgraded its popular eVive™ pulse wave therapy system to exceed expectations in high volume practices.

INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, to receive up to $5.4 Million over four years as part of the Defense Advanced Research Projects Agency (DARPA) contract worth up to $27.8 Million awarded to consortium led by the Icahn School of Medicine at Mount Sinai New York.

H.E. Nana Addo Dankwa Afkufo-Addo will accept Humanitarian Award on behalf of the Republic of Ghana.

According to a recent Qualtrics Survey conducted September 4th though September 11th, of over 200 respondents with mild to moderate sleep apnea, more than 70% said they would prefer to try the FDA cleared Bongo Rx over traditional CPAP therapy to treat their sleep apnea when given the choice.

InsightRX, a pioneer in precision medicine, announced today the closing of its $10 million Series A funding led by HealthX Ventures, with participation from Rock Health, OSF Healthcare, Leawood Venture Capital, Premier Inc., and earlier investor GreatPoint Ventures.

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at the B. Riley FBR Annual Consumer & Media Conference to be held October 3, 2019, at the Sofitel New York Hotel in New York City.

Investment will accelerate product development and innovation for the behavioral health industry